Literature DB >> 20355252

What are the hallmarks of cancer?

Yuri Lazebnik1.   

Abstract

The seminal article by Douglas Hanahan and Robert Weinberg on the hallmarks of cancer is 10 years old this year and its contribution to how we see cancer has been substantial. But, in embracing this view, have we lost sight of what makes cancer cancer?

Entities:  

Mesh：

Year:  2010        PMID： 20355252     DOI： 10.1038/nrc2827

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  22 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Molecular and cellular pathogenesis of benign prostatic hyperplasia.

Authors:  Keith L Lee; Donna M Peehl
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

Review 3.  Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors.

Authors:  Ibrahim Sozen; Aydin Arici
Journal:  Obstet Gynecol Clin North Am       Date:  2006-03       Impact factor: 2.844

4.  Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.

Authors:  Marlan R Hansen; Pamela C Roehm; Papri Chatterjee; Steven H Green
Journal:  Glia       Date:  2006-04-15       Impact factor: 7.452

Review 5.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

Review 6.  Benign liver tumors.

Authors:  Ian R Wanless
Journal:  Clin Liver Dis       Date:  2002-05       Impact factor: 6.126

Review 7.  Metastasis of benign tumor cells in tuberous sclerosis complex.

Authors:  Elizabeth Petri Henske
Journal:  Genes Chromosomes Cancer       Date:  2003-12       Impact factor: 5.006

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05

Review 10.  Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Authors:  Nikolas H Stoecklein; Christoph A Klein
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396
View more
  66 in total

1.  Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.

Authors:  Hideaki Kume; Satoshi Muraoka; Takahisa Kuga; Jun Adachi; Ryohei Narumi; Shio Watanabe; Masayoshi Kuwano; Yoshio Kodera; Kazuyuki Matsushita; Junya Fukuoka; Takeshi Masuda; Yasushi Ishihama; Hisahiro Matsubara; Fumio Nomura; Takeshi Tomonaga
Journal:  Mol Cell Proteomics       Date:  2014-03-31       Impact factor: 5.911

2.  Accurate reconstruction of the temporal order of mutations in neoplastic progression.

Authors:  Kathleen Sprouffske; John W Pepper; Carlo C Maley
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

3.  Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?

Authors:  Tamal Das; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2013-01-31       Impact factor: 2.800

Review 4.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

Review 5.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

6.  In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells.

Authors:  Dmitry A Nedosekin; Vladislav V Verkhusha; Alexander V Melerzanov; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Chem Biol       Date:  2014-05-08

Review 7.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis.

Authors:  Luisana Astudillo; Thiago G Da Silva; Zhiqiang Wang; Xiaoqing Han; Ke Jin; Jeffrey VanWye; Xiaoxia Zhu; Kelly Weaver; Taiji Oashi; Pedro E M Lopes; Darren Orton; Leif R Neitzel; Ethan Lee; Ralf Landgraf; David J Robbins; Alexander D MacKerell; Anthony J Capobianco
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

9.  Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.

Authors:  Rachel Sarig; Noa Rivlin; Ran Brosh; Chamutal Bornstein; Iris Kamer; Osnat Ezra; Alina Molchadsky; Naomi Goldfinger; Ori Brenner; Varda Rotter
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

Review 10.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.